| 000 | 01288 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511201228.0 | ||
| 264 | 0 | _c19901212 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0361-7742 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorstyn, G | |
| 245 | 0 | 0 |
_aTowards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors. _h[electronic resource] |
| 260 |
_bProgress in clinical and biological research _c1990 |
||
| 300 |
_a29-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aEtoposide _xadverse effects |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 700 | 1 | _aSheridan, W | |
| 700 | 1 | _aLieschke, G | |
| 700 | 1 | _aCebon, J | |
| 700 | 1 | _aLayton, J | |
| 700 | 1 | _aFox, R | |
| 773 | 0 |
_tProgress in clinical and biological research _gvol. 354B _gp. 29-36 |
|
| 999 |
_c1706842 _d1706842 |
||